[144] nCino, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for NCNO: The filing records a proposed sale of 241,850 shares of common stock through Merrill Lynch Pierce Fenner and Smith with an aggregate market value of $7,352,240. The sale is listed for approximately 09/08/2025 on Nasdaq. The shares were acquired in a private placement on 06/15/2020 from the issuer and were paid in cash. The filer reports no securities sold during the past three months. Several standard Form 144 attestations appear, including the signers representation that they are not aware of undisclosed material adverse information. The filing is missing explicit filer and issuer names and some contact fields are blank.

Positive

• Transaction details disclosed: Share count, aggregate market value, broker, acquisition date, and approximate sale date are provided.
• No recent sales reported: The filer discloses "Nothing to Report" for securities sold during the past three months.
• Standard attestations included: The filing contains the required representation about material nonpublic information and Rule 10b5-1 language.

Negative

• Filer and issuer identification missing: The form's tables do not provide explicit names for the filer or issuer, reducing transparency.
• Contact information incomplete: Submission contact fields appear blank, limiting ability to follow up for clarification.
• Approximate sale date only: The filing lists an approximate sale date rather than a firm transaction date, which leaves timing uncertain.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notification of an insider/affiliate sale; size and timing disclosed but filer and issuer names are omitted from the form.

The notice documents a planned sale of 241,850 common shares valued at $7,352,240 through Merrill Lynch with an approximate trade date of 09/08/2025. The acquisition source is a private placement dated 06/15/2020 and payment was cash. No sales in the prior three months are reported, which may indicate this is the first recent disposition requiring a Form 144 filing. Key disclosure gaps—specifically the absence of explicit filer and issuer names in the provided tables—limit the ability to link this sale to a particular insider or to assess ownership percentage and potential market impact. As a compliance notice, it signals intent to sell but does not by itself change fundamentals.

Corporate Governance Expert

TL;DR: The filing follows procedural requirements for a Rule 144 sale but omits identifying information, reducing transparency for stakeholders.

The form includes required transaction details: broker, share count, aggregate value, acquisition method and date, and an approximate sale date. It also contains the standard attestation regarding non-public material information and trading-plan language. However, the absence of explicit filer and issuer names and missing contact details undermines the disclosures completeness and may complicate verification by investors or regulators. From a governance perspective, clear identification of the selling party and relationship to the issuer is important for assessing potential signalling or conflicts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch Pierce Fenner and Smith One Bryant Park New York NY 10036	241850	7352240.00	115814720	09/08/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/15/2020	Private Placement	Issuer			241850	06/15/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does NCNO Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 241,850 common shares with an aggregate market value of $7,352,240 through Merrill Lynch, with an approximate sale date of 09/08/2025.

When and how were the shares being sold originally acquired?

The shares were acquired in a private placement on 06/15/2020 from the issuer and payment was made in cash.

Does the filing report any sales in the past three months for NCNO?

No. The filing explicitly states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale for NCNO?

The listed broker is Merrill Lynch Pierce Fenner and Smith, One Bryant Park, New York, NY.

Are the filer and issuer names provided in this Form 144 for NCNO?

No. The submission tables do not include explicit filer or issuer names in the provided content.